カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のバイオ医薬品分析検査サービス市場2022年～2026年

■ 英語タイトル：Global Biopharmaceutical Analytical Testing Services Market 2022-2026

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR40457-22）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR40457-22
■ 発行日：2022年4月21日
■ 調査対象地域：北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ
■ 産業分野：医薬品
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のバイオ医薬品分析検査サービス市場2022年～2026年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

テクナビオ社は、世界のバイオ医薬品分析検査サービス市場規模が2022年から2026年まで年平均12.41％成長し、28.3億ドルに達すると予測しています。本調査レポートでは、バイオ医薬品分析検査サービスの世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別（製薬・バイオテクノロジー企業、CRO）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の内容を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のバイオ医薬品分析検査サービス市場規模：エンドユーザー別（製薬・バイオテクノロジー企業、CRO）
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Biopharmaceutical Analytical Testing Services Market 2022-2026

Technavio has been monitoring the biopharmaceutical analytical testing services market and it is poised to grow by $ 2.83 bn during 2022-2026, accelerating at a CAGR of 12.41% during the forecast period. Our report on the biopharmaceutical analytical testing services market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advanced route optimization strengthens shippers, LSPs, and carriers, uninterrupted fast services, and a large return on investment.

The biopharmaceutical analytical testing services market analysis includes end-user segment and geographic landscape.
Technavio’s biopharmaceutical analytical testing services market is segmented as below:

By End-user
• pharma and biotech companies
• CROs

By Geographical Landscape
• North America
• Europe
• APAC
• South America
• The Middle East and Africa

This study identifies real-time reporting as one of the prime reasons driving the biopharmaceutical analytical testing services market growth during the next few years. Also, helping distributors and companies organize their delivery processes and optimal routes will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biopharmaceutical analytical testing services market covers the following areas:
• Biopharmaceutical analytical testing services market sizing
• Biopharmaceutical analytical testing services market forecast
• Biopharmaceutical analytical testing services market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biopharmaceutical analytical testing services market vendors that include Alphabet Inc., AMCS Group, Aptean Group of Companies, BluJay Solutions Inc., Caliper Corp., Dassault Systemes SE, Descartes Systems Group Inc., Environmental Systems Research Institute Inc., FLS GmbH, IFS World Operations AB, Microlise Group Plc, Nomadia, OptimoRoute Inc., ORTEC B.V, Prism Visual Software Inc., PTV Planung Transport Verkehr AG, Route4Me Inc., Routific Solutions Inc., Trimble Inc., Verizon Communications Inc., and Wise Systems Inc. Also, the biopharmaceutical analytical testing services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/biopharmaceutical-analytical-testing-services-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 24: Chart on End-user – Market share 2021-2026 (%)
o Exhibit 25: Data Table on End-user – Market share 2021-2026 (%)
o 5.2 Comparison by End-user
o Exhibit 26: Chart on Comparison by End-user
o Exhibit 27: Data Table on Comparison by End-user
o 5.3 Pharma and biotech companies – Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharma and biotech companies – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharma and biotech companies – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharma and biotech companies – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharma and biotech companies – Year-over-year growth 2021-2026 (%)
o 5.4 CROs – Market size and forecast 2021-2026
o Exhibit 32: Chart on CROs – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on CROs – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on CROs – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on CROs – Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by End-user
o Exhibit 36: Market opportunity by End-user ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 APAC – Market size and forecast 2021-2026
o Exhibit 50: Chart on APAC – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on APAC – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on APAC – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on APAC – Year-over-year growth 2021-2026 (%)
o 7.6 South America – Market size and forecast 2021-2026
o Exhibit 54: Chart on South America – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on South America – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on South America – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on South America – Year-over-year growth 2021-2026 (%)
o 7.7 Middle East and Africa – Market size and forecast 2021-2026
o Exhibit 58: Chart on Middle East and Africa – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Middle East and Africa – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Middle East and Africa – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Middle East and Africa – Year-over-year growth 2021-2026 (%)
o 7.8 Market opportunity By Geographical Landscape
o Exhibit 62: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 63: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 64: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 65: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 66: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 67: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 68: Matrix on vendor position and classification
o 10.3 Aptean Group of Companies
o Exhibit 69: Aptean Group of Companies – Overview
o Exhibit 70: Aptean Group of Companies – Product / Service
o Exhibit 71: Aptean Group of Companies – Key offerings
o 10.4 FLS GmbH
o Exhibit 72: FLS GmbH – Overview
o Exhibit 73: FLS GmbH – Product / Service
o Exhibit 74: FLS GmbH – Key offerings
o 10.5 Nomadia
o Exhibit 75: Nomadia – Overview
o Exhibit 76: Nomadia – Product / Service
o Exhibit 77: Nomadia – Key offerings
o 10.6 OptimoRoute Inc.
o Exhibit 78: OptimoRoute Inc. – Overview
o Exhibit 79: OptimoRoute Inc. – Product / Service
o Exhibit 80: OptimoRoute Inc. – Key offerings
o 10.7 ORTEC B.V
o Exhibit 81: ORTEC B.V – Overview
o Exhibit 82: ORTEC B.V – Product / Service
o Exhibit 83: ORTEC B.V – Key offerings
o 10.8 Prism Visual Software Inc.
o Exhibit 84: Prism Visual Software Inc. – Overview
o Exhibit 85: Prism Visual Software Inc. – Product / Service
o Exhibit 86: Prism Visual Software Inc. – Key offerings
o 10.9 Route4Me Inc.
o Exhibit 87: Route4Me Inc. – Overview
o Exhibit 88: Route4Me Inc. – Product / Service
o Exhibit 89: Route4Me Inc. – Key offerings
o 10.10 Routific Solutions Inc.
o Exhibit 90: Routific Solutions Inc. – Overview
o Exhibit 91: Routific Solutions Inc. – Product / Service
o Exhibit 92: Routific Solutions Inc. – Key offerings
o 10.11 Trimble Inc.
o Exhibit 93: Trimble Inc. – Overview
o Exhibit 94: Trimble Inc. – Business segments
o Exhibit 95: Trimble Inc. – Key offerings
o Exhibit 96: Trimble Inc. – Segment focus
o 10.12 Wise Systems Inc.
o Exhibit 97: Wise Systems Inc. – Overview
o Exhibit 98: Wise Systems Inc. – Product / Service
o Exhibit 99: Wise Systems Inc. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 100: Inclusions checklist
o Exhibit 101: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 102: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 103: Research methodology
o Exhibit 104: Validation techniques employed for market sizing
o Exhibit 105: Information sources
o 11.5 List of abbreviations
o Exhibit 106: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on End-user – Market share 2021-2026 (%)
Exhibits25: Data Table on End-user – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by End-user
Exhibits27: Data Table on Comparison by End-user
Exhibits28: Chart on Pharma and biotech companies – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharma and biotech companies – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharma and biotech companies – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharma and biotech companies – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on CROs – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on CROs – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on CROs – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on CROs – Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by End-user ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on APAC – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on APAC – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on APAC – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on APAC – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on South America – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on South America – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on South America – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on South America – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Middle East and Africa – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Middle East and Africa – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Middle East and Africa – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Middle East and Africa – Year-over-year growth 2021-2026 (%)
Exhibits62: Market opportunity By Geographical Landscape ($ million)
Exhibits63: Impact of drivers and challenges in 2021 and 2026
Exhibits64: Overview on Criticality of inputs and Factors of differentiation
Exhibits65: Overview on factors of disruption
Exhibits66: Impact of key risks on business
Exhibits67: Vendors covered
Exhibits68: Matrix on vendor position and classification
Exhibits69: Aptean Group of Companies – Overview
Exhibits70: Aptean Group of Companies – Product / Service
Exhibits71: Aptean Group of Companies – Key offerings
Exhibits72: FLS GmbH – Overview
Exhibits73: FLS GmbH – Product / Service
Exhibits74: FLS GmbH – Key offerings
Exhibits75: Nomadia – Overview
Exhibits76: Nomadia – Product / Service
Exhibits77: Nomadia – Key offerings
Exhibits78: OptimoRoute Inc. – Overview
Exhibits79: OptimoRoute Inc. – Product / Service
Exhibits80: OptimoRoute Inc. – Key offerings
Exhibits81: ORTEC B.V – Overview
Exhibits82: ORTEC B.V – Product / Service
Exhibits83: ORTEC B.V – Key offerings
Exhibits84: Prism Visual Software Inc. – Overview
Exhibits85: Prism Visual Software Inc. – Product / Service
Exhibits86: Prism Visual Software Inc. – Key offerings
Exhibits87: Route4Me Inc. – Overview
Exhibits88: Route4Me Inc. – Product / Service
Exhibits89: Route4Me Inc. – Key offerings
Exhibits90: Routific Solutions Inc. – Overview
Exhibits91: Routific Solutions Inc. – Product / Service
Exhibits92: Routific Solutions Inc. – Key offerings
Exhibits93: Trimble Inc. – Overview
Exhibits94: Trimble Inc. – Business segments
Exhibits95: Trimble Inc. – Key offerings
Exhibits96: Trimble Inc. – Segment focus
Exhibits97: Wise Systems Inc. – Overview
Exhibits98: Wise Systems Inc. – Product / Service
Exhibits99: Wise Systems Inc. – Key offerings
Exhibits100: Inclusions checklist
Exhibits101: Exclusions checklist
Exhibits102: Currency conversion rates for US$
Exhibits103: Research methodology
Exhibits104: Validation techniques employed for market sizing
Exhibits105: Information sources
Exhibits106: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の天然痘治療市場2022年～2026年
  • 世界の皮膚科用医薬品市場2022年～2026年
  • 世界のシコクビエ市場2022年～2026年
  • 世界のステアリングロボット市場2022年～2026年
  • 世界のオンライン衣料品レンタル市場2022年～2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR40457-22 )"世界のバイオ医薬品分析検査サービス市場2022年～2026年" (英文：Global Biopharmaceutical Analytical Testing Services Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。